• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

ASTRO ’17 Round-up: Novocure touts five-year results for Optune, chemo combo in newly-diagnosed glioblastoma patients

September 25, 2017 By Sarah Faulkner

Philips showcases latest radiation oncology workflow technologies

Royal PhilipsRoyal Philips (NYSE:PHG) touted its latest radiation oncology solutions at ASTRO today, including its RTdrive MR Prostate system, which combines imaging, MR-based auto-contouring and workflow management to come up with treatment plans for prostate cancer in 25 minutes.

The company’s RTdrive MR Prostate system uses Philips’ Ingenia MR-RT platform, MR-only simulation, auto-contouring and Pinnacle Auto-Planning.

“Oncology care teams strive to increase precision, accelerate time to treatment, improve patient care and enhance patient satisfaction,” Ardie Ermers, Philips’ GM of radiation oncology, said in prepared remarks. “Delivering on our commitment to provide meaningful innovations for patients and care providers, we have focused on developing solutions in radiation oncology to streamline workflows from start to finish.”

Philips’ Pinnacle 16 system includes a new user interface and new features like Deformable Image Registration and Intensity Modulated Proton Therapy, the company reported.

Philips also showcased a patient-centered imaging workflow, called iPatient for Big Bore CT. The system gives a standardized approach to simulation imaging with advanced 4D imaging applications. It can also manage a patient’s optimal radiation dose.

The company’s Ingenia MR-RT with MR-only simulation is also on display at ASTRO, Philips said. The simulation platform produces high-contrast MR images in the treatment position to help clinicians identify target organs and organs at risk.

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Oncology, Pharmaceuticals, Wall Street Beat Tagged With: Mayo Clinic, NovoCure, Royal Philips, viewray

IN CASE YOU MISSED IT

  • Dexcom Q3 earnings top forecasts, as it looks ahead to type 2 coverage
  • Sensonics launches human feasibility study for transmitter-free Eversense CGM
  • Enable Injections, Sanofi obtain approval for on-body myeloma therapy in Japan
  • Abbott sets Libre Duo glucose-ketone sensor US launch for December
  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS